Role of the active cycle of breathing technique combined with phonophoresis for the treatment of patients with chronic obstructive pulmonary disease (COPD): study protocol for a preliminary randomized controlled trial

Continual obstructive pulmonary illness (COPD) is a continual inflammatory lung illness characterised by coughing, the manufacturing of extra sputum, and dyspnea. Sufferers with excessively thick sputum could have frequent assaults or develop extra severe illness. The rules advocate airway clearance for sufferers with extreme sputum who’re hospitalized with COPD. The lively cycle of respiratory approach is the commonest non-pharmacological airway clearance approach utilized by physiotherapists. Nevertheless, the effectiveness of the approach shouldn’t be at all times assured. Energetic cycle of respiratory methods require the preliminary dilution of the sputum, normally by inhalation medicine, which can have restricted results.
 We suggest a single-blind randomized managed trial utilizing 75 hospitalized sufferers recognized with COPD with extreme sputum manufacturing. The sufferers might be divided into three teams. The intervention group will obtain lively cycle of respiratory methods mixed with phonophoresis. The 2 comparability teams might be handled with lively cycle of respiratory methods and phonophoresis, respectively. This system might be applied day by day for 1 week. The first outcomes might be adjustments in sputum viscosity and manufacturing, lung operate, and pulse oximetry.
Secondary outcomes embody the evaluation of COPD and anxiousness, measured by the COPD Evaluation Take a look at scale and the Nervousness Stock for Respiratory Illness, respectively; self-satisfaction; the diploma of cooperation; and the size of hospital keep. All final result measures, except for sputum manufacturing and extra secondary outcomes, might be assessed on the graduation of the examine and after 1 week’s intervention. Evaluation of variance might be used to research variations between the teams, and a p-value of lower than 0.05 (two-tailed) might be thought-about statistically vital.
Current research have discovered that phonophoresis decreases irritation, suggesting the potential of the mixed utilization of lively cycle of respiratory methods and phonophoresis. Subsequently, the intention of this examine is to discover the effectiveness and security of mixing lively cycle of respiratory approach and phonophoresis in treating COPD sufferers. This examine introduces a mixture of lively cycle of respiratory methods and phonophoresis to discover the affect of those interventions on sufferers hospitalized with COPD. If this mixed intervention is proven to be efficient, it could show to be a greater therapy for sufferers with COPD.

The impact of consecutive ambient air air pollution on the hospital admission from continual obstructive pulmonary illness within the Chengdu area, China

Hospitalisation dangers for continual obstructive pulmonary illness (COPD) have been attributed to ambient air air pollution worldwide. Nevertheless, an increase in COPD hospitalisations could point out a substantial enhance in fatality charge in public well being. The present examine focuses on the affiliation between consecutive ambient air air pollution (CAAP) and COPD hospitalisation to supply predictable early steering in the direction of estimates of COPD hospital admissions within the occasion of consecutive publicity to air air pollution.

Massive knowledge analytics had been collected from 3-year time collection recordings (from 2015 to 2017) of each air knowledge and COPD hospitalisation knowledge within the Chengdu area in China. Based mostly on the mixed results of CAAP and unit enhance in air pollutant concentrations, a quasi-Poisson regression mannequin was established, which revealed the affiliation between CAAP and estimated COPD admissions. The outcomes present the dynamics and outbreaks within the variations in COPD admissions in response to CAAP. Cross-validation and imply squared error (MSE) are utilized to validate the goodness of match.

In each short-term and long-term air air pollution exposures, Z check outcomes present that the COPD hospitalisation threat is larger for males than for ladies; equally, the prevalence of COPD hospital admissions within the group of aged individuals (> 65 years outdated) is considerably bigger than that in decrease age teams. The time lag between the air high quality and COPD hospitalisation can also be investigated, and a peak of COPD hospitalisation threat is discovered to lag 2 days for air high quality index (AQI) and PM10, and 1 day for PM2.5. The massive data-based predictive paradigm could be a measure for the early detection of a public well being occasion in post-COVID-19. The examine findings also can present steering for COPD admissions within the occasion of consecutive publicity to air air pollution within the Chengdu area.

Role of the active cycle of breathing technique combined with phonophoresis for the treatment of patients with chronic obstructive pulmonary disease (COPD): study protocol for a preliminary randomized controlled trial

Harnessing cell well being know-how to help lengthytime period continual sickness administration: exploring household caregiver help wants within the outpatient setting

 Household caregiving is a crucial public well being subject, significantly with the getting old inhabitants. Lately, cell well being (mHealth) know-how has emerged as a possible low-cost, scalable platform to handle caregiver help wants, and thereby alleviate the burden on caregivers. This examine sought to look at the help wants of household caregivers of their lived experiences of outpatient care to tell the event of a future mHealth intervention. We performed 20 semi-structured interviews in 2 outpatient hematopoietic cell transplant (HCT) clinics at a big tutorial medical heart within the Midwestern United States. A thematic evaluation was carried out to outline rising themes.
Qualitative knowledge evaluation recognized 5 main themes that HCT caregivers confronted: (I) life-style restrictions as a result of affected person’s immunocompromised state; (II) Unmet wants attributable to limitations within the present assets, together with unfamiliar medical duties with out crucial trainings; and (III) caregivers’ adaptive methods, together with reformation of social relationships with household and buddies. Based mostly on these findings, we recommend Three design issues to information the event of a future mHealth intervention.

Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E09C1802-192T 192 tests
EUR 1270
Description: A sandwich ELISA for quantitative measurement of Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E09C1802-48 1 plate of 48 wells
EUR 520
Description: A sandwich ELISA for quantitative measurement of Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E09C1802-96 1 plate of 96 wells
EUR 685
Description: A sandwich ELISA for quantitative measurement of Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E08C1802-192T 192 tests
EUR 1270
Description: A sandwich ELISA for quantitative measurement of Canine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E08C1802-48 1 plate of 48 wells
EUR 520
Description: A sandwich ELISA for quantitative measurement of Canine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E08C1802-96 1 plate of 96 wells
EUR 685
Description: A sandwich ELISA for quantitative measurement of Canine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E04C1802-192T 192 tests
EUR 1270
Description: A sandwich ELISA for quantitative measurement of Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E04C1802-48 1 plate of 48 wells
EUR 520
Description: A sandwich ELISA for quantitative measurement of Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E04C1802-96 1 plate of 96 wells
EUR 685
Description: A sandwich ELISA for quantitative measurement of Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E03C1802-192T 192 tests
EUR 1270
Description: A sandwich ELISA for quantitative measurement of Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E03C1802-48 1 plate of 48 wells
EUR 520
Description: A sandwich ELISA for quantitative measurement of Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E03C1802-96 1 plate of 96 wells
EUR 685
Description: A sandwich ELISA for quantitative measurement of Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E07C1802-192T 192 tests
EUR 1270
Description: A sandwich ELISA for quantitative measurement of Porcine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E07C1802-48 1 plate of 48 wells
EUR 520
Description: A sandwich ELISA for quantitative measurement of Porcine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E07C1802-96 1 plate of 96 wells
EUR 685
Description: A sandwich ELISA for quantitative measurement of Porcine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E06C1802-192T 192 tests
EUR 1270
Description: A sandwich ELISA for quantitative measurement of Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E06C1802-48 1 plate of 48 wells
EUR 520
Description: A sandwich ELISA for quantitative measurement of Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E06C1802-96 1 plate of 96 wells
EUR 685
Description: A sandwich ELISA for quantitative measurement of Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E05C1802-192T 192 tests
EUR 1270
Description: A sandwich ELISA for quantitative measurement of Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E05C1802-48 1 plate of 48 wells
EUR 520
Description: A sandwich ELISA for quantitative measurement of Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E05C1802-96 1 plate of 96 wells
EUR 685
Description: A sandwich ELISA for quantitative measurement of Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Anti-ZAP70 (Chronic Lymphocytic Leukemia Marker) Monoclonal Antibody

M00754-1 100ug/vial
EUR 397
Description: Mouse Monoclonal ZAP70 (Chronic Lymphocytic Leukemia Marker) Antibody. Validated in IHC and tested in Human.

ZAP-70 (Chronic Lymphocytic Leukemia Marker); Clone ZAP70/528 (Concentrate)

RA0453-C.1 0.1 ml
EUR 125

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC042035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405S conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC042035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405S conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC042046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405S conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC042046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405S conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC432035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF543 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC432035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF543 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC432046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF543 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC432046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF543 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC472035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF647 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC472035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF647 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC472046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF647 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC472046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF647 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCAP2035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCAP2035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCAP2046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCAP2046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC802035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC802035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC802046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC802046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC812035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC812035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC812046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC812046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC682035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF568 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC682035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF568 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC682046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF568 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC682046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF568 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC702035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF770 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC702035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF770 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC702046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF770 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC702046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF770 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC882035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF488A conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC882035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF488A conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC882046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF488A conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC882046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF488A conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC612035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF660R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC612035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF660R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC612046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF660R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC612046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF660R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC942035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF594 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC942035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF594 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC942046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF594 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC942046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF594 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCA2035-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), APC conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCA2046-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), APC conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNUB2035-100 100uL
EUR 264
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Concentration: 0.2mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNUB2035-50 50uL
EUR 405
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), 1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNUB2035-500 500uL
EUR 513
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Concentration: 0.2mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNUB2046-100 100uL
EUR 264
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Concentration: 0.2mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNUB2046-50 50uL
EUR 405
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), 1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNUB2046-500 500uL
EUR 513
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Concentration: 0.2mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCH2035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCH2035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCH2046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCH2046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC052035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405M conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC052035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405M conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC052046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405M conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC052046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405M conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCP2035-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), PerCP conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCP2046-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), PerCP conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCR2035-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), RPE conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCR2046-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), RPE conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC402035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF640R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC402035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF640R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC402046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF640R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC402046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF640R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCB2035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Biotin conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCB2035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Biotin conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCB2046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Biotin conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCB2046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Biotin conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC552035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF555 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC552035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF555 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC552046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF555 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC552046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF555 conjugate, Concentration: 0.1mg/mL

Chronic Lymphocytic Leukemia Deletion Region Gene 8 Protein (CLLD8) Antibody

abx430501-200ul 200 ul
EUR 384

Monoclonal ZAP70 (Chronic Lymphocytic Leukemia Marker) Antibody, Clone: SPM362

APR14716G 7 ml
EUR 484
Description: A Monoclonal antibody against Human ZAP70 (Chronic Lymphocytic Leukemia Marker). The antibodies are raised in Mouse and are from clone SPM362. This antibody is applicable in IHC, IF, FC

Monoclonal ZAP70 (Chronic Lymphocytic Leukemia Marker) Antibody, Clone: 2F3.2

APR14717G 7 ml
EUR 484
Description: A Monoclonal antibody against Human ZAP70 (Chronic Lymphocytic Leukemia Marker). The antibodies are raised in Mouse and are from clone 2F3.2. This antibody is applicable in IHC, IF, FC

Monoclonal ZAP70 (Chronic Lymphocytic Leukemia Marker) Antibody, Clone: ZAP70/528

APR14715G 7 ml
EUR 484
Description: A Monoclonal antibody against Human ZAP70 (Chronic Lymphocytic Leukemia Marker). The antibodies are raised in Mouse and are from clone ZAP70/528. This antibody is applicable in IHC, IF, FC

ZAP-70 (Chronic Lymphocytic Leukemia Marker); Clone ZAP70/528 (Concentrate)

RA0453-C.5 0.5 ml
EUR 300

ZAP-70 (Chronic Lymphocytic Leukemia Marker); Clone ZAP70/528 (Concentrate)

RA0453-C1 1 ml
EUR 500

CLIA kit for Human HYOU1 (Hypoxia Up Regulated 1)

E-CL-H0346 1 plate of 96 wells
EUR 584
Description: A sandwich CLIA kit for quantitative measurement of Human HYOU1 (Hypoxia Up Regulated 1) in samples from Serum, Plasma, Cell supernatant

ELISA kit for Human HYOU1 (Hypoxia Up Regulated 1)

E-EL-H0426 1 plate of 96 wells
EUR 534
Description: A sandwich ELISA kit for quantitative measurement of Human HYOU1 (Hypoxia Up Regulated 1) in samples from Serum, Plasma, Cell supernatant

ELISA kit for Human HYOU1 (Hypoxia Up Regulated 1)

ELK3096 1 plate of 96 wells
EUR 432
Description: A sandwich ELISA kit for detection of Hypoxia Up Regulated 1 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Monoclonal ZAP70 (Chronic Lymphocytic Leukemia Marker) Antibody, Clone: ZAP70/528 + 2F3.2

APR14714G 7 ml
EUR 484
Description: A Monoclonal antibody against Human ZAP70 (Chronic Lymphocytic Leukemia Marker). The antibodies are raised in Mouse and are from clone ZAP70/528 + 2F3.2. This antibody is applicable in IHC, IF, FC

Human Hypoxia Up Regulated 1 ELISA kit

E01H0132-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Human Hypoxia Up Regulated 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Hypoxia Up Regulated 1 ELISA kit

E01H0132-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Human Hypoxia Up Regulated 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Hypoxia Up Regulated 1 ELISA kit

E01H0132-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Human Hypoxia Up Regulated 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Hypoxia Up Regulated 1 ELISA kit

E01H0393-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Human Hypoxia Up Regulated 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Hypoxia Up Regulated 1 ELISA kit

E01H0393-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Human Hypoxia Up Regulated 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Hypoxia Up Regulated 1 ELISA kit

E01H0393-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Human Hypoxia Up Regulated 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

ELISA kit for Rat HYOU1 (Hypoxia Up Regulated 1)

E-EL-R2533 1 plate of 96 wells
EUR 534
Description: A sandwich ELISA kit for quantitative measurement of Rat HYOU1 (Hypoxia Up Regulated 1) in samples from Serum, Plasma, Cell supernatant

Human Hypoxia Up Regulated 1 (HYOU1) Protein

20-abx067168
  • EUR 578.00
  • EUR 258.00
  • EUR 1720.00
  • EUR 690.00
  • EUR 425.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

ELISA kit for Human T-cell acute lymphocytic leukemia protein 1 (TAL1)

KTE60462-48T 48T
EUR 332
Description: Quantitative sandwich ELISA for measuring Human T-cell acute lymphocytic leukemia protein 1 (TAL1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human T-cell acute lymphocytic leukemia protein 1 (TAL1)

KTE60462-5platesof96wells 5 plates of 96 wells
EUR 2115
Description: Quantitative sandwich ELISA for measuring Human T-cell acute lymphocytic leukemia protein 1 (TAL1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human T-cell acute lymphocytic leukemia protein 1 (TAL1)

KTE60462-96T 96T
EUR 539
Description: Quantitative sandwich ELISA for measuring Human T-cell acute lymphocytic leukemia protein 1 (TAL1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Human L1210 (Lymphocytic Leukemia) lysate

HCL-1284 100ug
EUR 238

Human K562 (Chronic Myelogenous Leukemia) lysate

HCL-1204 1 mg
EUR 524
The findings herein captured the household caregiver’s lived experiences throughout outpatient care. There was broad settlement that caregiving was difficult and disturbing. Thus, efficient and scalable interventions to help caregivers are wanted. This examine offered knowledge to information the content material and design of a future mHealth intervention within the outpatient setting.